These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26866976)

  • 1. Impaired glucose metabolism moderates the course of illness in bipolar disorder.
    Mansur RB; Rizzo LB; Santos CM; Asevedo E; Cunha GR; Noto MN; Pedrini M; Zeni M; Cordeiro Q; McIntyre RS; Brietzke E
    J Affect Disord; 2016 May; 195():57-62. PubMed ID: 26866976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar disorder course, impaired glucose metabolism and antioxidant enzymes activities: A preliminary report.
    Mansur RB; Rizzo LB; Santos CM; Asevedo E; Cunha GR; Noto MN; Pedrini M; Zeni-Graiff M; Gouvea ES; Cordeiro Q; Reininghaus EZ; McIntyre RS; Brietzke E
    J Psychiatr Res; 2016 Sep; 80():38-44. PubMed ID: 27281261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course.
    Mansur RB; Santos CM; Rizzo LB; Asevedo E; Cunha GR; Noto MN; Pedrini M; Zeni-Graiff M; Cordeiro Q; Vinberg M; Kapczinski F; McIntyre RS; Brietzke E
    Bipolar Disord; 2016 Jun; 18(4):373-8. PubMed ID: 27324989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Ostacher MJ; Perlis RH; Nierenberg AA; Calabrese J; Stange JP; Salloum I; Weiss RD; Sachs GS;
    Am J Psychiatry; 2010 Mar; 167(3):289-97. PubMed ID: 20008948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments.
    Steardo L; Fabrazzo M; Sampogna G; Monteleone AM; D'Agostino G; Monteleone P; Maj M
    J Affect Disord; 2019 Feb; 245():174-179. PubMed ID: 30391773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the number of previous mood episodes moderate the relationship between alcohol use, smoking and mood in bipolar outpatients?
    Ter Meulen WG; van Zaane J; Draisma S; Beekman ATF; Kupka RW
    BMC Psychiatry; 2017 May; 17(1):185. PubMed ID: 28506220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder.
    Lagerberg TV; Icick R; Andreassen OA; Ringen PA; Etain B; Aas M; Henry C; Bjella TD; Melle I; Bellivier F
    J Affect Disord; 2016 Jan; 190():286-293. PubMed ID: 26544611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
    Nolen WA; Luckenbaugh DA; Altshuler LL; Suppes T; McElroy SL; Frye MA; Kupka RW; Keck PE; Leverich GS; Post RM
    Am J Psychiatry; 2004 Aug; 161(8):1447-54. PubMed ID: 15285972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.
    Regenold WT; Thapar RK; Marano C; Gavirneni S; Kondapavuluru PV
    J Affect Disord; 2002 Jun; 70(1):19-26. PubMed ID: 12113916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
    Angst J; Azorin JM; Bowden CL; Perugi G; Vieta E; Gamma A; Young AH;
    Arch Gen Psychiatry; 2011 Aug; 68(8):791-8. PubMed ID: 21810644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients.
    Cassidy F; Ahearn E; Carroll BJ
    Am J Psychiatry; 1999 Sep; 156(9):1417-20. PubMed ID: 10484954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus.
    Rasgon NL; Kenna HA; Reynolds-May MF; Stemmle PG; Vemuri M; Marsh W; Wang P; Ketter TA
    Bipolar Disord; 2010 Aug; 12(5):504-13. PubMed ID: 20712751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes associated with comorbid posttraumatic stress disorder among patients with bipolar disorder.
    Passos IC; Jansen K; Cardoso Tde A; Colpo GD; Zeni CP; Quevedo J; Kauer-Sant'Anna M; Zunta-Soares G; Soares JC; Kapczinski F
    J Clin Psychiatry; 2016 May; 77(5):e555-60. PubMed ID: 27135375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiometabolic risks and omega-3 index in recent-onset bipolar I disorder.
    Wulsin LR; Blom TJ; Durling M; Welge JA; DelBello MP; Adler CM; McNamara RK; Strakowski SM
    Bipolar Disord; 2018 Nov; 20(7):658-665. PubMed ID: 29479787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder.
    Chang KD; Saxena K; Howe M; Simeonova D
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):25-32. PubMed ID: 20166793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program.
    Waxmonsky JA; Thomas MR; Miklowitz DJ; Allen MH; Wisniewski SR; Zhang H; Ostacher MJ; Fossey MD
    Gen Hosp Psychiatry; 2005; 27(5):321-8. PubMed ID: 16168792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
    Sylvia LG; Shelton RC; Kemp DE; Bernstein EE; Friedman ES; Brody BD; McElroy SL; Singh V; Tohen M; Bowden CL; Ketter TA; Deckersbach T; Thase ME; Reilly-Harrington NA; Nierenberg AA; Rabideau DJ; Kinrys G; Kocsis JH; Bobo WV; Kamali M; McInnis MG; Calabrese JR
    Bipolar Disord; 2015 Mar; 17(2):212-23. PubMed ID: 25130321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-relation between brain-derived neurotrophic factor and antioxidant enzymes in bipolar disorder.
    Mansur RB; Santos CM; Rizzo LB; Cunha GR; Asevedo E; Noto MN; Pedrini M; Zeni M; Cordeiro Q; McIntyre RS; Brietzke E
    Bipolar Disord; 2016 Aug; 18(5):433-9. PubMed ID: 27488494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines, metabolic dysfunction and illness course in bipolar disorder.
    Mansur RB; Rizzo LB; Santos CM; Asevedo E; Cunha GR; Noto MN; Pedrini M; Zeni M; Cordeiro Q; McIntyre RS; Brietzke E
    J Psychiatr Res; 2016 Mar; 74():63-9. PubMed ID: 26748249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.